跳至主要内容
临床试验/NCT03226262
NCT03226262已完成不适用

FFRangio Accuracy vs. Standard FFR

CathWorks Ltd.9 个研究点 分布在 4 个国家目标入组 382 人开始时间: 2017年9月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
382
试验地点
9
主要终点
Sensitivity and specificity of the dichotomously scored FFRangio measured index compared to invasive FFR

研究概览

简要总结

This is a prospective, observational, multi-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects, >18 years of age.
  • Patients with stable angina or unstable angina or NSTEMI, and in whom invasive FFR is being assessed in a non-culprit stenosis in at least one coronary artery.
  • Subject is undergoing invasive FFR with Adenosine, ATP or Papaverine used as hyperemic stimulus.
  • Provides written, informed consent (where required)

排除标准

  • Contraindication for FFR examination or administration of vasodilators.
  • Subject is presenting with acute infarct (STEMI) OR has documented prior STEMI on same side (right/left).
  • CTO in target vessel.
  • Prior CABG, heart transplant or valve surgery, or prior TAVI/TAVR.
  • Known LVEF ≤45%.
  • Arteries supplying akinetic or severe hypokinetic territories if already known based on prior imaging.
  • TIMI Grade 2 or lower at baseline.
  • Target lesion involves Left Main (stenosis >50%).
  • PCI with stent in target vessel in past 12 months, or target vessel involves in-stent restenosis.
  • Severe, diffuse disease defined as the presence of diffuse, serial gross luminal irregularities present in the majority of the coronary tree.
  • Target coronary vessel is supplied by major collaterals.

结局指标

主要结局

Sensitivity and specificity of the dichotomously scored FFRangio measured index compared to invasive FFR

时间窗: 1 hour

Sensitivity and specificity of the dichotomously scored FFRangio measured index per vessel as compared with invasively-derived FFR; Index ≤ 0.80 is scored "positive" while Index \> 0.8 is negative.

次要结局

  • Continuously scored FFR (FFRangio and Invasive FFR).(1 hour)
  • Procedure related Adverse and Serious Adverse Events(1 hour)
  • Accuracy, Positive predictive value and negative predictive value per vessel and per lesion(1 hour)
  • Sensitivity and specificity of the dichotomously scored FFRangio measured index per lesion as measured by the site.(1 hour)
  • Device Success(1 hour)
  • Comprehensiveness of the FFRangio User Manual in providing adequate instructions(1 hour)
  • Usability of FFRangio(1 hour)
  • Device related Adverse and Serious Adverse Events(1 hour)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验